Incidence of bacteraemia after urodynamic study

The Journal of Hospital Infection
R OnurA Semercioz

Abstract

The aim of the present study was to determine the incidence of bacteraemia after urodynamic study (UDS) in patients with lower urinary tract symptoms, and to evaluate the role of bacteraemia as a morbidity factor related to UDS. A total of 57 patients (mean age: 52.8 years, range: 8-76 years) were evaluated by UDS. Prophylactic antibiotics were not administered to any of the patients before the procedure. Before UDS, urine cultures were examined for the presence of infection of the urinary tract (UTI). Venous blood was taken before and just after performing UDS. There was no bacterial growth in blood cultures of any patients before the UDS. Of the 57 patients, two had bacteriuria before study. After UDS, bacteraemia was determined in four (7%) out of 55 patients. The two patients with a bacteriuria before the procedure also had positive blood cultures. Infectious complications are the most important morbidity factors related to the UDS. Despite the use of strict aseptic techniques, bacteraemia may occur in patients undergoing UDS. The results of the present study may help when counselling patients who are to undergo UDS.

References

Apr 1, 1978·British Journal of Urology·S Walter, R Vejlsgaard
Jan 1, 1986·Scandinavian Journal of Urology and Nephrology·M ArpiB Timmermann
Oct 26, 1999·Neurourology and Urodynamics·D PorruE Usai
Feb 13, 2001·The Journal of Hospital Infection·G W Yardy, R A Cox
May 16, 2002·BJU International·I OkorochaI Gould

❮ Previous
Next ❯

Citations

Nov 8, 2008·Acta Diabetologica·Aydin YenilmezTurgut Donmez
May 21, 2013·The Kaohsiung Journal of Medical Sciences·Cenk GürbüzTurhan Caşkurlu
Jan 15, 2014·Taiwanese Journal of Obstetrics & Gynecology·Shih-Wei TsaiKuan-Hui Huang
Apr 22, 2008·European Urology·A M Jikke BootsmaAstrid Goossens
Jan 10, 2006·BJOG : an International Journal of Obstetrics and Gynaecology·G Alessandro DigesuVik Khullar
May 17, 2011·International Journal of Urology : Official Journal of the Japanese Urological Association·Ryoichi HamasunaTetsuro Matsumoto
Sep 24, 2014·Journal of Chemotherapy·Vincenzo Mirone, Marco Franco
Mar 28, 2017·Neurourology and Urodynamics·Anne P CameronMichael J Kennelly
Oct 19, 2012·The Cochrane Database of Systematic Reviews·Richard FoonPallavi Latthe
Sep 13, 2007·Neurourology and Urodynamics·Pallavi M LatthePhilip Toozs-Hobson
Sep 25, 2019·Topics in Spinal Cord Injury Rehabilitation·Janae PreeceChristina Ching
Nov 23, 2006·International Journal of Urology : Official Journal of the Japanese Urological Association·Kok Bin LimStephanie Fook-Chong
May 22, 2018·Obstetrics & Gynecology Science·Un Ju ShinHee Dong Chae

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Bladder Carcinoma In Situ

Bladder Carcinoma In Situ is a superficial bladder cancer that occurs on the surface layer of the bladder. Discover the latest research on this precancerous condition in this feed.

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.